Structural and cellular study demonstrates that N-linked glycans maintain non-toxic prion conformations in cultured cells, highlighting a mechanism that suppresses neurotoxicity.
The C-terminal domain of cellular prion protein (PrP C ) contains two N-linked glycosylation sites, the occupancy of which impacts disease pathology. In this study, we demonstrate that glycans at these sites are required to maintain an intramolecular interaction with the N-terminal domain, mediated through a previously identified copper-histidine tether, which suppresses the neurotoxic activity of PrP C . NMR and EPR spectroscopy demonstrate that the glycans refine the structure of the protein's interdomain interaction. Using whole-cell patch-clamp electrophysiology, we further show that cultured cells expressing PrP molecules with mutated glycosylation sites display large, spontaneous inward currents, a correlate of PrP-induced neurotoxicity. Our findings establish a structural basis for the role of N-linked glycans in maintaining a non-toxic, physiological fold of PrP C .
No takes yet. Share an insight, caveat, or question.
Schilling et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: